"The team at Astera Cancer Care in East Brunswick will help you navigate the complex world of cancer treatment. From initial diagnosis to developing a complete cancer treatment plan, you will have a team of medical oncologists, radiation oncologists, and breast surgeons with you every step of the way. We also offer cancer support care and financial advocacy options as part of our commitment to our patients to provide an unparalleled, supported patient experience."

During the past decade, Regional Cancer Care Associates, LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 8 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Cancer Care Associates, LLC" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Celgene" with 3 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Astex Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Cancer Care Associates, LLC" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Regional Cancer Care Associates, LLC" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Lymphoma, Non-Hodgkin" (3 trials), "Lymphoma, Large B-Cell, Diffuse" (2 trials), "Multiple Myeloma" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Regional Cancer Care Associates, LLC" in a lesser frequency.

Most popular intervention types in "Regional Cancer Care Associates, LLC" are "Drug" (17 trials), "Biological" (4 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Nivolumab" (3 trials), "Bevacizumab" (2 trials), "Dexamethasone" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Regional Cancer Care Associates, LLC" are 18 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Regional Cancer Care Associates, LLC". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Regional Cancer Care Associates, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Cancer Care Associates, LLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".